| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on ,
From the Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, Ky. * To whom correspondence should be addressed. E-mail: moliterno{at}uky.edu.
Related Article:
Accepted on ,
Antiplatelet Polypharmacy in Primary Percutaneous Coronary Intervention. Trying to Understand When More Is Better
Ahmed Abdel-Latif MD, MSPH and David J. Moliterno MD*
Key words: Editorials
angioplasty
aspirin
myocardial infarction
platelets
Circulation 2009 119: 3207-3214.
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |